InsidersTradesSigma
申报总数
公司
▲ 买入（2 笔）
▼ 卖出（2 笔）
内部人交易记录
首席执行官已披露买入
2
已披露卖出
2
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
信号历史
Browse the detailed record of transactions filed by Kidron Nadav, 董事长兼首席执行官. Insider active across 3 companies, notably Oramed Pharmaceuticals INC.. In total, 25 reports have been logged. Split: 2 buys · 2 sells. Total volume traded: €7.8m. Activity tracked since 9 August 2021. The latest transaction was filed on 21 August 2026 (X). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Kidron Nadav
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报25 总计
10,000 股@ US$1.50Ordinary SharesSEC:0001104659-26-100937:0
44,818 股@ US$3.311.6% 占其流量Common StockSEC:0001213900-26-037447:0
7,657 股0Ordinary Shares, no par value per shareSEC:0001178913-26-001814:0
167,005 股0Common StockSEC:0001213900-26-031013:0
100,000 股0Common StockSEC:0001213900-26-028291:0
109,000 股0Common StockSEC:0001213900-26-009479:0
232,640 股0Common StockSEC:0001213900-26-001280:0
141,000 股0Common StockSEC:0001213900-25-012239:0
433,500 股Common StockSEC:0001213900-25-001168:0
45,000 股Common StockSEC:0001213900-24-095931:0
329,000 股Common StockSEC:0001209191-24-001151:0
120,000 股Common StockSEC:0001209191-23-033145:0
279,000 股Common StockSEC:0001209191-23-024939:0
26,000 股@ US$2.0390.3% 占其流量Common StockSEC:0001209191-23-019367:0
标准退出：2023年6月14日 (T+90)
100,000 股@ US$2.011.2% 占其流量Common StockSEC:0001209191-23-018956:0
标准退出：2023年6月12日 (T+90)
25,000 股0Common StockSEC:0001209191-22-054879:0
34,000 股Common StockSEC:0001209191-22-043768:0
150,000 股Common StockSEC:0001213900-22-001613:0
150,000 股Common StockSEC:0001213900-22-000818:0
31,728 股@ US$12.988.1% 占其流量Common StockSEC:0001213900-21-068231:0
220,000 股@ US$20.10522.21% mcap23.8% 占其流量Common StockSEC:0001213900-21-063945:0
100,000 股Common StockSEC:0001213900-21-063944:0
20,000 股Common StockSEC:0001213900-21-063983:0
100,000 股Common StockSEC:0001213900-21-046407:0
220,000 股@ US$20.105283.8% 占其流量Common StockSEC:0001213900-21-041711:0
25 条申报中的 25 条
About Kidron Nadav
KIDRON NADAV is Président-Directeur Général. He has 24 filings in total, and in the recent sampled filings covered here the activity runs from 2021-08-11 to 2026-03-31, with EUR 237504 of buys and EUR 7536153 of sells; the modal transaction nature is Attribution. He is also linked to Oramed Pharmaceuticals INC. as President and CEO and to Lifeward Ltd. as Director.
